The idea that transcriptional programs are highly dysregulated in cancers and that cancers become over-dependent on certain factors that control gene expression has led to increased efforts to inhibit transcriptional CDKs, such as CDK9 [21]. This evidence concerns the gene CDK9 and cancer.